Suppression of lncRNA HOXA11-AS/miR-124 Axis Inhibits Glioma Progression

被引:0
作者
Yishan He
Xinguang Qiu
机构
[1] the First Affiliated Hospital of Zhengzhou University,Department of Breast Surgery
[2] the First Affiliated Hospital of Zhengzhou University,Department of Thyroid Surgery
来源
Cell Biochemistry and Biophysics | 2021年 / 79卷
关键词
Glioma; miR-124; lncRNA HOXA11-AS; Cell proliferation; Invasion; Apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
Our aim was to clarify the regulations of lncRNA HOXA11-AS (HOXA11-AS) played on the progression of glioma as well as to investigate the mechanisms by which HOXA11-AS modulated development of glioma. This study confirmed the regulations of miR-124 and HOXA11-AS on the progression of glioma. Here, HOXA11-AS was overexpressed and miR-124 was underexpressed in glioma. Expression of miR-124 was negatively related to that of HOXA11-AS. Silencing of HOXA11-AS suppressed cell proliferation, invasion, and promoted apoptosis in glioma cells in vitro. Moreover, inhibition of HOXA11-AS expression repressed glioma xenograft tumor growth. Expression of miR-124 was repressed by HOXA11-AS functioning as sponge. In addition, miR-124 knockdown partially abolished the inhibitory roles of HOXA11-AS downregulation in glioma cells. Conclusively, this study suggested that silencing of HOXA11-AS restrained proliferation, invasion, induced apoptosis of glioma cells, and repressed xenograft growth via modulating miR-124 expression and thus inhibited glioma progression.
引用
收藏
页码:815 / 822
页数:7
相关论文
共 203 条
  • [1] Ostrom QT(2015)CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012 Neuro-Oncology 17 iv1-iv62
  • [2] Gittleman H(2007)The 2007 WHO classification of tumours of the central nervous system Acta Neuropathologica 114 97-109
  • [3] Fulop J(2016)Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a Journal of Experimental & Clinical Cancer Research 35 90-177
  • [4] Liu M(2012)Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233 Journal of Neuro-Oncology 110 163-684
  • [5] Blanda R(2010)Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance Neoplasia 12 675-5430
  • [6] Kromer C(2008)PTEN signaling in brain: neuropathology and tumorigenesis Oncogene 27 5416-1488
  • [7] Wolinsky Y(2007)RNA maps reveal new RNA classes and a possible function for pervasive transcription Science 316 1484-938
  • [8] Kruchko C(2010)The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation Molecular Cell 39 925-34757
  • [9] Barnholtz-Sloan JS(2015)A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer Oncotarget 6 34745-259
  • [10] Louis DN(2016)A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma Cancer Letters 373 251-358